Outcome for pediatric acute promyelocytic leukemia patients at Children's Oncology Group sites on the Leukemia Intergroup Study CALGB 9710 (Alliance)-Reference-Cited by-同舟云学术

Outcome for pediatric acute promyelocytic leukemia patients at Children's Oncology Group sites on the Leukemia Intergroup Study CALGB 9710 (Alliance)

Published:2018-11-04 Issue:3 Volume:66 Page:e27542
ISSN:1545-5009
Container-title:Pediatric Blood & Cancer
language:en
Short-container-title:Pediatr Blood Cancer

Author:

Kutny Matthew A.¹^ORCID,Geyer Susan²,Laumann Kristina M.³,Gregory John⁴,Willman Cheryl L.⁵,Stock Wendy⁶,Larson Richard A.⁶,Powell Bayard L.⁷,Feusner James H.⁸

Affiliation:

1. Department of Pediatrics; Division of Hematology/Oncology; University of Alabama at Birmingham; Birmingham Alabama

2. Health Informatics Institute; University of South Florida; Tampa Florida

3. Alliance Statistics and Data Center; Mayo Clinic; Rochester Minnesota

4. Atlantic Health System; Goryeb Children's Hospital; Morristown New Jersey

5. Department of Pathology; School of Medicine; University of New Mexico Cancer Center; Albuquerque; New Mexico

6. Section of Hematology/Oncology; Department of Medicine; University of Chicago; Chicago Illinois

7. Section on Hematology and Oncology; Comprehensive Cancer Center of Wake Forest University School of Medicine; Winston-Salem North Carolina

8. Division of Hematology/Oncology; Children's Hospital and Research Center Oakland; Oakland California

Funder

Cancer and Leukemia Group B and Alliance for Clinical Trials in Oncology

Children's Oncology Group

National Cancer Institute

Publisher

Wiley

Subject

Oncology,Hematology,Pediatrics, Perinatology and Child Health

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/pbc.27542/fullpdf

Reference35 articles.

1. Treatment of children with acute promyelocytic leukemia: results of the first North American Intergroup trial INT0129;Gregory;Pediatr Blood Cancer,2009

2. Early death rate in acute promyelocytic leukemia remains high despite all-trans retinoic acid;Park;Blood,2011

3. Continuing high early death rate in acute promyelocytic leukemia: a population-based report from the Swedish Adult Acute Leukemia Registry;Lehmann;Leukemia,2011

4. Causes and prognostic factors of remission induction failure in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and idarubicin;la Serna;Blood,2008

5. Molecular remission in PML/RAR alpha-positive acute promyelocytic leukemia by combined all-trans retinoic acid and idarubicin (AIDA) therapy. Gruppo Italiano-Malattie Ematologiche Maligne dell'Adulto and Associazione Italiana di Ematologia ed Oncologia Pediatrica Cooperative Groups;Mandelli;Blood,1997

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long-term survival outcome of childhood acute myeloid leukemia: a 43-year experience in Thailand, a resource-limited country;Leukemia & Lymphoma;2024-07-26

2. Coagulopathy in pediatric acute promyelocytic leukemia in Bangladesh: A single-center, prospective study;Pediatric Hematology Oncology Journal;2024-06

4. Childhood Acute Promyelocytic Leukemia;Reference Module in Biomedical Sciences;2023

5. Childhood acute promyelocytic leukemia in a pediatric cancer referral center in Baghdad, Iraq. Improved results with ATRA extended consolidation;Leukemia & Lymphoma;2022-08-01